ViewRay® Newsroom

ViewRay® to Present at The JMP Securities Life Sciences Conference

June 13, 2017

CLEVELAND, June 13, 2017 — ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer is scheduled to present at The JMP Securities Life Sciences Conference in New York, NY. 

Event: The JMP Securities Life Sciences Conference
Date: Tuesday, June 20
Time: 2:00pm ET

An audio webcast of the Company’s presentation will be available on the investor relations section of ViewRay’s website at A replay of the webcast will be available for 90 days after the date of the presentation.

About ViewRay

ViewRay®, Inc. (Nasdaq: VRAY) designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.

ViewRay and MRIdian are registered trademarks of ViewRay, Inc.


Michael Saracen
Senior Director, Marketing
ViewRay, Inc.
Phone: +1 408-242-2994


Copyright © 2018 ViewRay, Inc.. All rights reserved   -   Contact ViewRay